Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2014 Feb 1.

Published in final edited form as: Biol Blood Marrow Transplant. 2012 Nov 27;19(2):173–179. doi: 10.1016/j.bbmt.2012.11.016

Table 3.

Outcomes of patients in CR1 versus beyond CR1

		Autologous				Allogeneic

		CR1		Non-CR1		CR1		Non-CR1

Outcome event	N	Prob (95% CI)	N	Prob (95% CI)	N	Prob (95% CI)	N	Prob (95% CI)	P-value^a
NRM	48		57		30		80
@ 1 year		2 (0–10)		9 (3–18)		23 (10–39)		27 (17–37)	<0.001
@ 5 years		4 (1–13)		12 (5–22)		23 (10–39)		30 (20–40)	<0.001
Progression/Relapse	48		57		30		80
@ 1 year		13 (5–24)		51 (38–63)		24 (10–39)		51 (40–62)	<0.001
@ 5 years		18 (8–30)		61 (47–73)		27 (13–44)		51 (40–62)	<0.001
PFS	48		57		30		80
@ 1 year		85 (71–93)		40 (27–52)		53 (34–69)		22 (14–32)	<0.001
@ 5 years		78 (63–88)		27 (16–40)		50 (30–66)		19 (11–29)	<0.001
Overall survival	48		57		30		81
@ 1 year		85 (72–93)		42 (29–54)		53 (34–69)		23 (14–33)	<0.001
@ 5 years		83 (69–91)		31 (19–44)		53 (34–69)		20 (12–30)	<0.001

Abbreviations NRM = Non relapse mortality; PFS = progression-free survival; PROB = probability; CI = confidence interval.